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Polydimethylsiloxane (PDMS) modulates CD38
expression, absorbs retinoic acid and may perturb
retinoid signalling
Kathryn Futrega,*a Jianshi Yu,c Jace W. Jones,c Maureen A. Kane,c William B. Lott,a
Kerry Atkinsona and Michael R. Doran*ab
Polydimethylsiloxane (PDMS) is the most commonly used material in the manufacture of customized cell
culture devices. While there is concern that uncured PDMS oligomers may leach into culture medium and/
or hydrophobic molecules may be absorbed into PDMS structures, there is no consensus on how or if
PDMS influences cell behaviour. We observed that human umbilical cord blood (CB)-derived CD34+ cells
expanded in standard culture medium on PDMS exhibit reduced CD38 surface expression, relative to cells
cultured on tissue culture polystyrene (TCP). All-trans retinoic acid (ATRA) induces CD38 expression, and
we reasoned that this hydrophobic molecule might be absorbed by PDMS. Through a series of experiments
we demonstrated that ATRA-mediated CD38 expression was attenuated when cultures were maintained
on PDMS. Medium pre-incubated on PDMS for extended durations resulted in a time-dependant reduction
of ATRA in the medium and increasingly attenuated CD38 expression. This indicated a time-dependent ab-
sorption of ATRA into the PDMS. To better understand how PDMS might generally influence cell behaviour,
Ingenuity Pathway Analysis (IPA) was used to identify potential upstream regulators. This analysis was
performed for differentially expressed genes in primary cells including CD34+ haematopoietic progenitor
cells, mesenchymal stromal cells (MSC), and keratinocytes, and cell lines including prostate cancer epithe-
lial cells (LNCaP), breast cancer epithelial cells (MCF-7), and myeloid leukaemia cells (KG1a). IPA predicted
that the most likely common upstream regulator of perturbed pathways was ATRA. We demonstrate here
that ATRA is absorbed by PDMS in a time-dependent manner and results in the concomitant reduced ex-
pression of CD38 on the cell surface of CB-derived CD34+ cells.
Introduction
Polydimethylsiloxane (PDMS) is a silicone-based elastomer
that is widely used to fabricate custom-made lab-on-a-chip cell
culture devices.1,2 PDMS is an attractive material for cell cul-
ture, as its use for device fabrication is relatively inexpensive;
it is considered non-cytotoxic, is gas permeable, and optically
transparent. Previous reports suggest that cells cultured in
the presence of PDMS can behave differently to those cultured
in traditional tissue culture polystyrene (TCP).1,3,4 Possible ar-
tefacts that might modify cell behaviour include uncured
PDMS oligomers leaching into culture medium or absorption
of hydrophobic molecules from the media into the PDMS.
The small dimensions commonly used in microfluidic biore-
actors and related culture systems result in a high PDMS sur-
face area to medium volume ratio,5 which can potentially am-
plify these artefacts.
PDMS has been shown to absorb small hydrophobic mole-
cules including pharmaceuticals such as ciprofloxacin and
paclitaxel.6 Nile red, a hydrophobic fluorophore, was shown
to strongly absorb into PDMS and could not be washed away
from PDMS microchannels using detergent and/or water.4 Af-
ter incubating media containing 1 nM estrogen in the pres-
ence of PDMS, 50% of the estrogen had absorbed after 1 hour
and 90% was lost from the medium after 24 hours.7 The ab-
sorption of molecules by PDMS was shown to be related to
the logarithm of the octanol–water partition coefficient (log P)
of the molecule.8 Molecules having a log P < 2.5 were mini-
mally absorbed (<10% in 4.5 hours) into PDMS channels,
while molecules with log P > 2.5 were extensively absorbed
into PDMS channels (≥75% after 0.5 hours). Fat-soluble me-
dia components such as lipid soluble vitamins and lipid-
derived hormones have high log P values (≥6) and would be
expected to absorb readily into PDMS.9
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Herein, we show that when umbilical cord blood (CB)-de-
rived CD34+ cells were cultured in the presence of PDMS,
there was a significant increase in the proportion of cells that
lost CD38 expression and thus an increase in the number of
CD38− cells. CD38 cell surface expression has been routinely
used to separate CD34+ progenitor cells into subpopulations
that are likely (CD38−) or not likely (CD38+) to contain sub-
populations of haematopoietic stem cells (HSC).10 CD38 is a
cyclic ADP ribose hydrolase whose expression can be induced
by all-trans retinoic acid (ATRA) via a retinoic acid (RA) re-
sponse element contained within the first intron of the
gene.11 As ATRA is both hydrophobic and it up-regulates
CD38 expression,9,11 we reasoned that ATRA absorption into
PDMS and depletion from culture medium might be causing
the observed increased yield of CD38− cells in PDMS cultures.
We performed the following five studies to better charac-
terize the influence of PDMS on cell cultures. (1) We quanti-
fied CD38 surface expression on human CB-derived CD34+
cells cultured in the presence of PDMS or TCP; (2) we sorted
fresh CB cells into CD34+CD38− and CD34+CD38+ cell
populations, and cultured them in ATRA-supplemented me-
dium in the presence of PDMS or TCP; (3) we cultured CD34+
cells in ATRA-supplemented medium that had been pre-
incubated for different durations of time in the presence of
PDMS or TCP; (4) we measured the relative ATRA concentra-
tion in ATRA-supplemented medium that had been pre-
incubated for different durations of time in the presence of
PDMS or TCP; and (5) we used the Upstream Regulator Analy-
sis tool in Ingenuity Pathway Analysis (IPA) software to pre-
dict the likely cause of gene expression changes observed
when cells were cultured in standard base medium in the
presence of PDMS or TCP. IPA analysis was performed for
CD34+ haematopoietic progenitor cells, mesenchymal stromal
cells (MSC), normal human epidermal keratinocytes (NHEK),
prostate cancer epithelial cells (LNCaP), breast cancer epithe-
lial cells (MCF-7), and myeloid leukaemia cells (KG1a).
Materials and methods
CD34+ cell isolation and culture
CB-derived CD34+ cells were either isolated in our laboratory
or purchased from StemCell Technologies (Cat#: 70008).
Fresh CB was collected at the Mater Hospital in Brisbane
from full-term births after obtaining informed consent from
mothers. Ethics approval was granted by the Mater Health
Services Human Research Ethics Committee and the Queens-
land University of Technology Human Ethics Committee
(Ethics number: 1100000210). CD34+ cell isolation from CB
was performed within 24 hours of collection. To isolate the
mononuclear cell fraction, CB was diluted 1 : 2 with PBS/2
mM EDTA, layered onto 15 mL of Ficoll-Paque Plus (GE
Healthcare) and centrifuged at 420 × g for 30 minutes. Mono-
nuclear cells were collected from the Ficoll-plasma interface
and diluted with PBS/2 mM EDTA and centrifuged at 300 × g
for 10 minutes. CD34+ cells were isolated using the CD34
MicroBead Kit (Miltenyi) as per manufacturer's instructions.
CD34+ cell purity was assessed by flow cytometry after
staining cells with conjugated mouse anti-CD34 antibody
(Miltenyi) and analysing them on a LSRII flow cytometer
(BD). CD34+ cell purity was always >90%.
CB-derived CD34+ cells were cultured in X-VIVO 15 media
(Lonza, Cat#: 04-418Q) supplemented with human recombi-
nant cytokines: 100 ng mL−1 stem cell factor (SCF, Amgen),
100 ng mL−1 thrombopoietin peptide (TPO peptide,12 Auspep
Pty), and 50 ng mL−1 FMS-like tyrosine kinase 3 (Flt-3) ligand,
(Miltenyi), with or without 10% fetal bovine serum (FBS;
Gibco), as specified. CD34+ cells were expanded in 2% O2
and 5% CO2 at 37 °C, or as specified.
Flow cytometry characterization of CD34+ expansion cultures
Expansion of CB-derived CD34+ cells and cell surface marker
expression was evaluated for cells grown on TCP or PDMS, af-
ter 7 days. Fluorescence conjugated mouse anti-human anti-
bodies including CD34-APC and CD38-PE (both from
Miltenyi) were used for cell-surface marker analysis and
stained 1 : 10 in 50 μL of MACS buffer (Miltenyi) at 4 °C for
15 minutes. Unstained and single colour control tubes were
prepared to aid in flow cytometry cell gating and to adjust for
spectral overlap. Conjugated isotype controls were used to en-
sure staining specificity. Cells were enumerated using fluoro-
spheres (Beckman Coulter, Cat#: 7547053), which were added
to the cell tubes before analysis. Flow cytometry was
performed on a LSRII. The following formula was used to cal-
culate cell numbers: total cells = [(cells counted)/(fluoro-
spheres counted)] × fluorospheres/μL × μL of cell suspension.
Flow cytometry data was analysed using FlowJo software
(TreeStar, Oregon, USA).
Retinoic acid (RA) quantification
ATRA was purchased from Sigma-Aldrich (St. Louis, MO) and
4,4-dimethyl-RA (internal standard) was purchased from To-
ronto Research Chemicals. Optima LC/MS grade water, aceto-
nitrile, and formic acid were purchased from Fisher Scientific
(Pittsburgh, PA). RA was extracted from media under yellow
lights as previously described using a liquid–liquid
extraction.13–15 RA was quantified using fast LC-multistage
tandem mass spectrometry (LC-MRM3) using a Shimadzu
Prominence UPLC coupled to an AB Sciex 5500 QTRAP with
atmospheric pressure chemical ionization operated in posi-
tive ion mode.16
Study 1: influence of PDMS on CD38 surface expression in
CD34+ cell expansion cultures
Here we contrasted the expression of CD38 on CD34+ cells
following 7 day expansion on either TCP or PDMS. PDMS cul-
ture plates were prepared by casting PDMS (Sylgard 184, Dow
Corning) into the bottom of culture wells in well plates.
PDMS polymer was prepared by combining the polymer and
curing agent at a 10 : 1 ratio, mixed vigorously and degassed
to remove air bubbles. 25 μL of liquid PDMS was added to
cover the bottom of wells in a 96 well plate (Corning). The
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PDMS plates were cured overnight in an 80 °C oven. PDMS-
containing plates were sterilized by submerging in 70% etha-
nol for 1 hour, followed by repeated rinses of wells with PBS
as described previously.17
Replicate cultures were maintained in atmospheres of 2%,
10% or 20% O2, all with 5% CO2 and at 37 °C. CD34
+ cell cul-
tures were initiated with 2 × 103 CD34+ cells per 96-well (5 ×
103 cells per mL), harvested at day 7 and analysed by flow cy-
tometry as described above. Cell expansion and CD38 expres-
sion were characterized for all oxygen concentrations, and in
the presence or absence of PDMS.
Study 2: behaviour of sorted CD38− and CD38+ cells on PDMS
Here we sorted fresh CD34+ cells into CD38− and CD38+ sub-
populations (MoFlo Astrios, Beckman Coulter) and evaluated
their phenotype following 7 days of expansion on TCP or
PDMS. Replicate cultures were supplemented with 1 nM
ATRA.
PDMS plates were fabricated similarly to above, with the
exception of using 48 well plates. PDMS volumes were in-
creased to 100 μl to cover the bottom surfaces of 48-well
plates (Nunc) prior to curing. Two different medium condi-
tions were evaluated: (1) control medium, X-VIVO 15, and (2)
X-VIVO 15 medium supplemented with 1 nM ATRA. All me-
dium contained cytokines. Cells were harvested at day 7 and
counted as well as characterized for CD34 and CD38 surface
expression by flow cytometry.
Study 3: effect of ATRA on CD38 cell surface expression and
the impact of medium pre-incubation on TCP or PDMS over
time
To further understand the temporal process of ATRA absorp-
tion in PDMS, we pre-incubated ATRA-supplemented medium
on TCP or PDMS, and then used this medium to expand
CD34+ cells. X-VIVO 15 medium was supplemented with vari-
ous concentrations of ATRA including 0 nM (control, 0.1%
DMSO) or 0.01, 0.1, 1, 10, 100 nM ATRA, and pre-incubated
for a specified number of days, prior to cell expansion. A rep-
licate study was performed where the X-VIVO 15 medium was
additionally supplemented with 10% FBS.
All medium formulations were pre-incubated in 48-well
plates in the absence or presence of PDMS (cured at the bot-
tom of wells). Each well was filled with 600 μL of the speci-
fied medium. The wells in the outer-most layer of the 48-well
plates were filled with sterile water to minimise evaporation
of medium during the incubation period. All media were pre-
incubated for 1, 2, 3, or 5 days in a 2% O2 and 5% CO2 incu-
bator at 37 °C, in the dark. All subsequent cell expansion was
performed in fresh 48-well TCP plates (Nunc) that did not
contain PDMS. 500 μL of the TCP or PDMS pre-incubated me-
dium was transferred to fresh 48-well plates. 50 μL of cell
suspension, containing 6 × 103 CD34+ cells, was added to 500
μL of pre-incubated media along with a concentrated cyto-
kine cocktail. Cells were harvested at day 7 and counted and
characterized for CD34 and CD38 surface expression by flow
cytometry.
Study 4: measurement of ATRA concentration in medium
after pre-incubation on PDMS or TCP
To confirm the reduction of ATRA concentration as a result
of PDMS absorption, ATRA was measured in medium pre-
incubated on TCP or PDMS using fast LC-MRM3 as described
above. Medium was spiked with varying concentrations of
ATRA and incubated on TCP or PDMS for the indicated num-
ber of days, as described in study 3 above. Pre-incubated me-
dium was collected and frozen prior to analysis. The relative
distribution of other RA isomers including 9-cis-RA, 9,13-di-
cis-RA, and 9-cis-RA was also determined in both media.
Study 5: upstream regulator prediction for TCP versus PDMS
cell cultures
To gain further insight into what pathways might be
perturbed in PDMS-containing cultures, we performed micro-
array gene expression and pathway analysis across a range of
different cell types. We used CD34+ haematopoietic cells from
two different CB donors, bone marrow (BM)-derived mesen-
chymal stromal cells (MSC) from two donors (MSC donor-1 =
55 year old male at passage 3 and MSC donor-2 = 42 year old
female at passage 4), normal human epithelial keratinocyte
population (NHEK), prostate cancer epithelial cells (LNCaP),
breast cancer epithelial cells (MCF-7), and myeloid leukaemia
cells (KG1a).
All cell populations were cultured in their respective base
medium. Any ATRA present in the culture would have been
derived from FBS or human serum albumin supplementation
contained within these standard medium formulations. Par-
allel cultures were maintained for 4 days in the presence or
absence of PDMS. CD34+ cells were cultured in X-VIVO 15,
supplemented with cytokines as described above, and addi-
tionally analysed on day 6 of culture. Four replicate wells
were prepared for each time point and for each CB donor.
MSC were isolated from BM aspirates as described previ-
ously.17 The Mater Health Services Human Research Ethics
Committee and the Queensland University of Technology Hu-
man Ethics Committee approved aspirate collection (Ethics
number: 1541 A). NHEK were purchased from Lonza (Cat#
00192906) and cultured in the KBM-Gold Keratinocyte Basal
Medium (Lonza, Cat#: 00192151) supplemented with KGM-
Gold BulletKit (Lonza, Cat# 00192060) (used at passage 4).
MCF-7, LNCaP and KG1a were obtained from the American
Type Culture Collection (ATCC). MSC, LNCaP, and MCF-7
were cultured in low glucose DMEM containing 10% FBS and
PenStrep. KG1a were cultured in RPMI medium containing
10% FBS and PenStrep. Three replicate wells were prepared
for each MSC donor and cell line. CD34+ cells and MSC were
cultured in 2% O2 and 5% CO2 and all other cells were cul-
tured in 20% O2 and 5% CO2, all at 37 °C.
To rule out confounding effects associated with differen-
tial cell attachment to PDMS versus TCP, adherent cells were
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prepared differently than the previous non-adherent CD34+
cell cultures. For this study, all adherent cells were permitted
to attach to TCP plates overnight first. All adherent cells were
seeded at 50 × 103 cells per well in 6 well plates with 4 ml of
media. KG1a cells were seeded at two densities, 5 × 103 and
50 × 103 cells per well (6 well plates), and prepared like the
adherent cultures. On the following day a sterile PDMS disk
with a diameter of 2 cm and a thickness of 2 mm was gently
placed on top of the culture medium in the PDMS test cul-
tures. The PDMS discs continued to float over the 4 day ex-
periment without sinking. Following the culture period, cells
were washed with PBS and total RNA was isolated using the
RNeasy Mini kit (Qiagen) with an on-column DNAse (Qiagen)
digestion step as per manufacturer's instructions. RNA qual-
ity was assessed using a 2100 Bioanalyzer and RNA 6000
Nano Kit (both from Agilent Technologies) as per manufac-
turer's instruction.
Microarray gene expression analysis was performed by the
Australian Genome Research Facility (AGRF, Melbourne, Aus-
tralia) as follows. The quality and quantity of human total
RNA was confirmed on the Agilent Bioanalyzer 2100 by the
AGRF. A total of 500 ng of total RNA was then prepared for
hybridisation to the Illumina HumanHT-12 Expression
BeadChip by preparing a probe cocktail (cRNA at 0.05 μg
μl−1) that included GEX-HYB Hybridisation Buffer (supplied
with the BeadChip). A total hybridisation volume of 15 μL
was prepared for each sample and loaded into a single array
on the BeadChip. The chip was then hybridised at 58 °C for
16 hours with rocking. Following hybridisation, the chip was
washed as per manufacturer's manual. Chips were then
coupled with Cy3 and scanned in the Illumina iScan Reader.
The scanner operating software, GenomeStudio version 1.9.0,
was used to convert the signal on the array into a TXT file for
analysis. The sample probe profile and control probe profile
files were read into the statistical programming language R
(version 3.1.2)18 and underwent quality control, using the
Bioconductor19 packages lumi20 and arrayQualityMetrics.21 All
samples passed QC. The data were processed using the Bio-
conductor package limma,22,23 and underwent normexp back-
ground correction using negative controls, quantile normali-
zation and were then log2 transformed. The control probes
were removed. All probes not expressed in the samples of
interest were removed. A linear model was fitted contrasting
the different sets, resulting in all differentially expressed
genes under a false discovery rate of 5%. The relative reliabil-
ity of each array was estimated as described previously.23
Contrasts were carried out to compare the differential gene
expression of the various cell types grown in the absence or
presence of PDMS.
Significantly differentially expressed genes (P < 0.05; log
fold change of greater or less than 0.2) were subsequently
uploaded to Ingenuity Pathway Analysis (IPA; Qiagen) and
the Upstream Regulator Analysis tool was used to identify up-
stream regulators that were significantly changed across the
different cell types. Predicted upstream regulators with posi-
tive z-scores greater than 2 were considered activated and
those with negative z-scores less than −2 were considered
inhibited. Z-scores were exported from IPA and used to create
a heat map using GENE-E software (Broad Institute, MIT
Cambridge, United States) for upstream regulator pathways
in the absence of PDMS (i.e. regulator pathways that were
perturbed in the presence of PDMS have a positive z-score).
Statistical analysis
Data were presented as the mean ± standard deviation (SD)
for 4 replicate samples, or as specified. Statistical significance
of data between different conditions was evaluated using
ANOVA in Graphpad Prism software. A significance level was
set at 0.05, with asterisk representing the P value obtained in
each comparison (*P < 0.05, **P < 0.01, ***P < 0.001, and
****P < 0.0001). Statistical analysis for microarray gene ex-
pression studies were performed by the AGRF and described
in the relevant sections.
Results and discussion
Results from each of the five studies are described in the rel-
evant sections below.
Study 1: influence of PDMS on CD38 surface expression in
CD34+ cell expansion cultures
While we had previously observed that there was differential
CD38 cell surface expression in CD34+ expansion cultures
maintained on TCP or PDMS in 2% O2 atmospheres, we were
uncertain if this artefact was associated with hypoxia or
PDMS itself. We considered hypoxia as a potential effector
due to the pooling of cells observed on PDMS, which we rea-
soned could result in an altered local hypoxic microenviron-
ment. Replicate cultures were maintained at three different
O2 concentrations, 2%, 10% and 20% O2, on either TCP or
PDMS. We characterized total cell expansion, the percentage
of CD34+ progenitor cells, and the percentage of CD38− cells
resulting in each culture (Fig. 1). Total cell expansion was
sensitive to O2 concentration, with the greatest expansion ob-
served in a 2% O2 atmosphere (Fig. 1A). This is consistent
with previous reports showing improved haematopoietic pro-
genitor cell expansion in hypoxic atmospheres.24,25 There was
a modest inverse correlation between total fold expansion
and the percentage of CD34+ cells within the expanded
populations (Fig. 1A & B). This is consistent with the general
loss of hematopoietic progenitor cells, marked by CD34+, dur-
ing CB expansion.26 A profound difference was observed in
the percentage of CD38− cells derived from cultures
maintained on TCP versus PDMS (Fig. 1C). In all cases, when
CD34+ cells were expanded on PDMS, more than 80% of the
cells were CD38 negative. In contrast, when CD34+ cells were
expanded on TCP only, approximately 55% of the cells were
CD38−. These data indicated that PDMS, not oxygen, caused
the observed reduction in CD38 expression, and the in-
creased yield of CD38− cells.
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Study 2: behaviour of sorted CD38− and CD38+ cells on PDMS
Our first study used CB cells enriched for CD34+ expression.
CD34+ cell populations derived from CB contain subpopula-
tions that are either CD38− or CD38+. Previous studies have
reported that long-term engrafting cells are contained within
the CD38− fraction of CD34+ cells (∼1–10% of CD34+ cells in
CB).27 It was unclear if the greater number of CD38− cells gen-
erated from PDMS cultures were being derived from the origi-
nal CD38− cell population, or if the PDMS was causing a
greater number of CD38− cells to be generated from the
starting fraction of CD38+ cells. To delineate this mechanism
we sorted the CB cells into CD34+CD38− and CD34+CD38+
populations and cultured these cells on either TCP or PDMS.
In this experiment we also included media supplemented with
ATRA. This control was included because ATRA is known to
up-regulate CD38 expression,11 and because it is a hydropho-
bic molecule that could potentially be absorbed by PDMS.9
The percentage yield of CD34+ and CD38− cells, which
were generated from the sorted CD34+CD38− and
CD34+CD38+ populations, is summarized in Fig. 2. In control
cultures, which did not include exogenously added ATRA, vir-
tually all of the sorted CD34+CD38− cells remained CD38−
when cultured on either TCP or PDMS. In contrast, sorted
CD34+CD38+ cells produced populations which were ∼75%
and ∼85% CD38− when cultured on TCP or PDMS, respec-
tively. These data suggested that the presence of PDMS accel-
erated the derivation of CD38− cells from the originally
CD38+ sorted cell population. This pattern of CD38− cell deri-
vation is consistent with previous studies that have shown
that serum-free culture of CD34+ cells results in the genera-
tion of a largely CD38− cell population.10 As serum-free cul-
tures of CD34+ cell populations generally converge to become
CD38−, it is logical to assume that the starting CD34+CD38−
cell population (∼1–10% of CD34+ cells in CB27) remains
CD38−, and the starting CD34+CD38+ (∼90–99% of CD34+
cells in CB) is the population that undergoes phenotype
change and becomes CD38−. In standard culture medium
(without added ATRA), CD38 loss occurred more rapidly on
PDMS, yielding a greater number of CD38− cells.
The addition of 1 nM ATRA to TCP cultures of
CD34+CD38− cells or CD34+CD38+ cells drove a significant in-
crease in CD38 surface expression, with virtually no cells
remaining that were CD38− at the end of the culture period
(Fig. 2, black bars in boxed area), compared to controls (no
exogenous ATRA added). In contrast, when 1 nM ATRA
supplemented cultures were maintained on PDMS this effect
was attenuated, and a significant CD38− population was
present at the end of the culture period, relative to TCP
(Fig. 2, grey bars versus black bars in boxed area). These data
suggest that PDMS modulated the ATRA effect on CD38 sur-
face expression in these cultures. As previously mentioned,
ATRA is a hydrophobic molecule that could absorb into
PDMS,9 and ATRA depletion would be expected to dampen
ATRA-sensitive CD38 expression.11
Study 3: effect of ATRA on CD38 cell surface expression and the
impact of medium pre-incubation on TCP or PDMS over time
The data from Fig. 2 suggested that PDMS absorbed ATRA,
and that depletion of ATRA from the medium could be mod-
ulating CD38 expression in PDMS cultures. We expected that
Fig. 1 CD34+ cell expansion on TCP versus PDMS. (A) Total cell expansion, (B) percentage of expanded cells that were CD34+, and (C) percentage
of expanded cells that were CD38−. Bars represent the means ± SD of 6 replicate wells (*P < 0.05, **P < 0.01, ***P < 0.001).
Fig. 2 Expansion of CD34+CD38− cells (A) and CD34+CD38+ cells (B) on TCP or PDMS. Expansion cultures were performed in 2 different culture
media, as specified on the x-axis. Control medium contained X-VIVO 15 medium plus cytokines. +ATRA medium contained X-VIVO 15 medium plus
cytokines and supplemented with 1 nM ATRA. Bars represent the means ± SD of 4 replicate wells (*P < 0.05, **P < 0.01, ***P < 0.001).
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extended durations of pre-incubation of medium on PDMS
would further reduce CD38 cell surface expression.
To determine if the duration of time that medium was
exposed to PDMS influenced subsequent CD38 surface expres-
sion in CD34+ expansion cultures, medium was pre-incubated
either on TCP or PDMS for 1, 2, 3, or 5 days. Medium prepara-
tions were also spiked with varying concentrations of ATRA
(0, 0.01, 0.1, 1, 10, or 100 nM), with or without FBS, to deter-
mine the degree of hydrophobic molecule absorption that
could be expected on PDMS. Pre-incubation of medium on
PDMS, particularly medium supplemented with low concentra-
tions of ATRA (up to 1 nM), or FBS, incrementally attenuated
CD38 surface expression (Fig. 3 and 4, boxed regions).
The boxed region in Fig. 3 highlights the percentage of
CD38− cells in cultures where the medium had been
supplemented with 0.1 nM ATRA and pre-incubated for either
1, 2, 3 or 5 days on TCP or PDMS. While extended pre-
incubation on TCP had minimal effect on the percentage of
CD38− cells in cultures (Fig. 3A), the percentage of CD38− cells
increased significantly the longer that medium was pre-
incubated on PDMS (Fig. 3B – 17% for 1 day pre-incubated, in-
creasing to 30% for 5 days pre-incubated). When ATRA supple-
mentation was increased to 10 nM, even 5 days pre-incubation
on PDMS was insufficient to attenuate CD38 surface expres-
sion. This suggested that at these higher ATRA concentrations,
there was sufficient ATRA, not pre-absorbed by PDMS, to stim-
ulate CD38 expression and completely deplete cultures of
CD38− cells. Cumulatively, these results indicated that ATRA
was increasingly absorbed by PDMS over time.
The control FBS medium in Fig. 4 contained no exoge-
nously added ATRA. Nevertheless, there was a substantial in-
crease in the percentage of CD38− cells in response to ex-
tended pre-incubation of control medium on PDMS (17% for
1 day pre-incubated, increasing to 30% for 5 days pre-incu-
bated). There was no temporal effect of pre-incubation of the
FBS supplemented medium on TCP. We interpreted this
larger change in CD38− percentage in FBS-containing media
as an indication that the FBS-containing media contained a
greater initial quantity of hydrophobic molecules that might
induce CD38 surface expression than the serum-free media.
Previous studies have shown that medium supplementation
with FBS caused an increase in CD38 surface expression and
depleted cultures of CD38− cells.10 While our data do not in-
dicate what FBS components are being absorbed into the
PDMS, FBS is known to contain an assortment of hydropho-
bic molecules, including retinoic acid isoforms and precur-
sors,28,29 which could be depleted in a manner similar to that
of the exogenously added ATRA.
TCP and PDMS pre-incubation of medium supplemented
with 0.1 nM ATRA (boxed areas in Fig. 4A and B) gave a simi-
lar pattern of results as seen for serum-free medium (Fig. 3).
Again, extended pre-incubation of FBS-containing medium
on TCP resulted in minimal changes in CD38− cell yield,
while extended pre-incubation on PDMS substantially in-
creased the number of CD38− cells. This reinforced the no-
tion that ATRA was being absorbed into the PDMS, and that
hydrophobic molecules from the FBS did not appear to be
saturating the PDMS or obstructing the absorption process.
Study 4: measurement of ATRA concentration in medium
after pre-incubation on PDMS or TCP
We quantified ATRA remaining in cell-free culture media
incubated on TCP or PDMS using fast LC-MRM3.16 As shown
in Fig. 5, the rate of ATRA depletion was greater in media
incubated on PDMS, relative to TCP controls, supporting
the notion that ATRA was absorbed by PDMS over time. In
media that was initially spiked with 1 nM of ATRA or greater,
we observed that on day 1, 2, and 3, ATRA concentrations
in PDMS incubated medium averaged 20.4 ± 11.7% less
than TCP incubated medium (P < 0.05). After 5 days of
media incubation, the percentage of ATRA was approximately
Fig. 3 Impact of serum-free medium pre-incubation on TCP or PDMS. (A) CD34+ cells cultured in X-VIVO 15 medium that had been pre-
incubated on TCP for the specified number of days, and (B) as in (A), but pre-incubated on PDMS for the specified number of days. Cells were cul-
tured for 7 days on TCP after the pre-incubation period, and characterized for the percentage of cells with phenotype CD38−. Bars represent the
mean ± SD of 4 replicate wells (*P < 0.05, **P < 0.01, ***P < 0.001). Each PDMS bar in (B) was greater than the equivalent TCP bar in (A) at
P < 0.05.
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10.6 ± 4.5% lower in the PDMS incubated media than TCP
incubated media, but this difference was only statistically
significant for the 100 nM ATRA condition (P < 0.05). These
results show that in addition to the natural conversion of
ATRA into different isomers under cell-free culture condi-
tions over time,30 PDMS contributes to the increased rate of
ATRA depletion from the culture medium via absorption.
The addition of FBS to media appeared to reduce the rate
of ATRA depletion from the medium into PDMS. While a
trend toward lower ATRA concentrations was observed in
PDMS incubated media supplemented with FBS, compared to
TCP, this difference was not statistically significant. FBS also
protected ATRA from isomerization into less biologically ac-
tive isomers (Fig. 6). Isomerization was extensively observed
in media without FBS, with 13-cis-RA being the predominant
isomer to accumulate as ATRA concentrations decreased. 13-
cis-RA is considered to be an inactive form of RA, and must
be converted to RA receptor binding isomers by cellular
mechanisms.30
Using our detection method, media supplemented with
10% FBS contained low levels of ATRA (0.03 ± 0.03 nM), while
the levels of ATRA in the commercial serum-free media
(X-VIVO 15) were below detectable levels.
PDMS-based absorption model
Based on our data, we conceptually model how PDMS ab-
sorbs ATRA and how this modulates CD38 expression
(Fig. 7). In this model, trace amounts of ATRA in the culture
medium drive an increase in CD38 expression on CD34+
cells. In this model, there is no depletion of ATRA into or on
to the TCP culture vessel, and the trace ATRA remains in the
culture medium and maintains CD38 expression on cultured
CD34+ cells. By contrast, ATRA is absorbed into PDMS and is
depleted from the culture medium, resulting in a down regu-
lation of CD38 and an increased number of CD38− cells.
Therefore, in addition to the chemical and cellular conver-
sion of ATRA into less biologically active RA isomers, the
time-dependent depletion of ATRA from cell culture medium
is accelerated by its absorption into PDMS.
Data from studies 1–4 suggest that the model proposed in
Fig. 7 is plausible. In study 1 we demonstrated that the
Fig. 4 Impact of serum supplemented medium pre-incubation on TCP or PDMS. (A) CD34+ cells cultured in X-VIVO 15 medium plus 10% FBS that
had been pre-incubated on TCP for the specified number of days, and (B) as in (A), but pre-incubated on PDMS for the specified number of days.
Cells were cultured for 7 days on TCP after the pre-incubation period, and characterized for the percentage of cells with phenotype CD38−. Bars
represent the mean ± SD of 4 replicate wells (*P < 0.05, **P < 0.01, ***P < 0.001). Each PDMS bar in (B) was greater than the equivalent TCP bar
in (A) (P < 0.05).
Fig. 5 The percentage of ATRA retrieved from media after pre-incubation on TCP or PDMS over time. Graphs are shown for serum-free and 10%
FBS-containing media that had been spiked at time zero with (A) 1 nM ATRA, (B) 10 nM ATRA, and (C) 100 nM ATRA. Percentages were normalised
to the initial ATRA added (% of control). Differences between TCP and PDMS values were statistically significant (P < 0.05) for day 1, 2, and 3 for
serum-free media (−FBS) and on day 5 for 10 nM ATRA supplemented condition.
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culture of CD34+ cells on PDMS resulted in an increased per-
centage of CD38− cells. In study 2 we demonstrated that
PDMS increased the percentage of CD38− cells from sorted
populations of CD34+CD38+ cells, relative to TCP. Critically,
study 2 also demonstrated that the addition of ATRA to cul-
ture medium drove an increase in CD38 expression on CB
CD34+ cells, but that this was attenuated by maintaining the
cultures on PDMS. The first two studies indicated that cul-
ture in the direct presence of PDMS affected cell phenotype.
However, if the absorption of hydrophobic molecules into
PDMS was affecting CD38 expression, then pre-incubation of
medium on PDMS surfaces would be sufficient to elicit a sim-
ilar phenotype change. We tested this premise in study 3 by
pre-incubating medium supplemented with different concen-
trations of ATRA on PDMS or TCP and then cultured CD34+
cells in the pre-incubated medium. At ATRA concentrations
of ≤1 nM, pre-incubation of medium on PDMS for extended
time periods (1–5 days) resulted in an incremental attenua-
tion of the ATRA-driven CD38 surface expression. In other
words, more CD38− cells were derived from cultures where
the medium had been pre-incubated for longer periods of
time on PDMS. This suggests, as shown in Fig. 7, that ATRA
was being absorbed into the PDMS over time and that direct
contact with the PDMS was not necessary to elicit the change
in CD38 phenotype.
Study 5: upstream regulator prediction for TCP versus PDMS
cell cultures
Because PDMS has become the material of choice for lab-on-
a-chip devices, we were interested to see if PDMS culture
would have a similar effect across a range of different cell
types. We used microarray gene expression and pathway anal-
ysis to find potential upstream regulators that might be iden-
tified by prediction software in IPA. In this analysis, we in-
cluded the following cell types: CD34+ haematopoietic cells
from two different CB donors (cultured for 4 and 6 days), as
well as 4 day cultures from two different BM-derived MSC do-
nors, NHEK, LNCaP, MCF-7, and KG1a. Parallel TCP and
PDMS cultures were analysed. We evaluated log fold change
(log FC) for differentially expressed genes (P < 0.05) in the
absence and presence of PDMS. Log FC values (>0.2 and
≤0.2; P < 0.05) for each cell type were uploaded to IPA and
the Upstream Regulator Analysis tool was used to identify po-
tential upstream regulator molecules in response to PDMS
culture. This analysis tool predicts upstream regulators from
gene expression data reported in the literature and compiled
in the Ingenuity Knowledge base.31
Fig. 8 shows a heatmap of z-scores from IPA software for
predicted upstream regulators based on associated gene
networks that were activated (positive z-score) or inhibited
(negative z-score) in the absence of PDMS (i.e. when regulator
is not ‘absorbed’). IPA ranked tretinoin (ATRA) as the most
probable upstream regulator perturbed on PDMS across cell
types when all the differentially expressed genes were
uploaded (Fig. 8A). However, the z-scores were not always ≥2
(value cut-off for significantly activated). The tretinoin
(ATRA)-network associated z-scores were as follows: MSC
donor-1, 2.6; MSC donor-2, not significant; MCF-7, 2.9;
NHEK, 1.4; LNCaP, 3.3; KG1a at high density, 0.3; KG1a at
Fig. 6 Retinoic acid (RA) isomer distribution in media after pre-
incubation on TCP or PDMS over time. Serum-free and FBS containing
media were analysed for the percentage of total RA that was in the
form of (A) ATRA, (B) 9-cis-RA, (C) 9,13-di-cis-RA, and (D) 13-cis-RA. The
% ATRA of total RA was significantly decreased at all measured time
points compared to time zero supplemented media in (A) (P < 0.001).
Fig. 7 Model of ATRA absorption into PDMS and influence on CD38 expression. In studies 1–4 we demonstrated that PDMS absorbed ATRA,
resulting in a corresponding decrease in CD38 surface expression on culture expanded CD34+ cells. This figure shows schematically how ATRA
absorption into PDMS (right panel), but not TCP (left panel), correlates with an increase in the number of CD38− cells.
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low density, −0.4; CD34+ expanded cells from CB donor-1 on
day 4, 2.3 and on day 6, 4.7; and CD34+ expanded cells from
CB donor-2 on day 4, 1.2 and on day 6, 0.7. We also repeated
the analysis in IPA, entering only up-regulated genes or
down-regulated genes, as it has been suggested that
analysing these gene changes separately may affect pathway
predicted outcomes.32 Using only up-regulated genes, the tre-
tinoin (ATRA) activation z-scores were ≥2 for all cell types, ex-
cept for KG1a (Fig. 6B).
All cell populations used in this gene pathway analysis ex-
periment were cultured in standard medium without exoge-
nous ATRA addition. All of the media used in these studies
would be expected to contain trace amounts of ATRA. The
serum-free media (X-VIVO 15) contained human serum albu-
min, which would be expected to carry small quantities of
retinoids.28,29 The FBS, utilized in most of the medium for-
mulations in this study, is known to contain a range of
retinoic acid isoforms and precursors.28,29
Other upstream regulators predicted by IPA that were
changed in the presence of PDMS included cholesterol
and calcitriol (active form of vitamin D) (Fig. 6B). This is
not surprising as both molecules contain relatively hydro-
phobic regions,33,34 which could bind PDMS and make
these molecules less available to cells. Upstream regulators
that were not contained in the culture media, but ranked as
potential upstream regulators (e.g. transcription factors
HIF1A, SREBF1, and SREBF2, and chromatin-binding pro-
tein NUPR1), must be indirectly affected by other exogenous
molecules.
Conclusion
While PDMS is the most common material used in the fabri-
cation of custom built culture devices, an increasingly recog-
nized artefact of PDMS culture is the propensity of this mate-
rial to absorb small hydrophobic molecules from the culture
medium.4 Such artefacts would be expected to be amplified
in microfluidic devices where the surface area to volume ratio
is large.5 Herein, we demonstrated that CD38 surface expres-
sion on cultured CD34+ cells was attenuated when these cells
were cultured in the presence of PDMS.
ATRA is known to be a chemically unstable molecule in
cell culture media, even in the absence of viable cells. ATRA
is subject to photoreactivity and chemical conversion to other
forms of RA that may be less biologically active.30 As ATRA is
both hydrophobic and up-regulates CD38 surface expres-
sion,11 we reasoned that ATRA absorption into PDMS might
be the cause of the increased down regulation of CD38 ex-
pression in PDMS cultures. Based on this hypothesis, we con-
ceptually modelled this process as shown in Fig. 7. In this
model, trace amounts of ATRA in the culture medium drive
an increase in CD38 expression on CD34+ cells. In both TCP
and PDMS-containing culture vessels, ATRA is subject to
chemical conversion to other RA isomers. However, on TCP
ATRA is retained in the culture medium to a greater extent
and up-regulates CD38 expression on cultured CD34+ cells.
By contrast, ATRA is absorbed into PDMS and is depleted
from the culture medium, resulting in a more rapid down
regulation of CD38 and an increased number of CD38− cells.
As a result of absorption, exposure of culture media to PDMS
exacerbates the loss of ATRA in culture medium and results
in an altered cell phenotype.
Different cell populations would be expected to differ in
their sensitivity to retinoid signalling, and thus the impact of
PDMS might be expected to be variable depending on the cell
type. Even within a single lineage, retinoid signalling can
change with cell maturation. For example, primitive bone
marrow haematopoietic progenitor cells (CD34+CD38−) have
been characterised by muted retinoic acid signalling, despite
having functional retinoic acid biosynthesis machinery.35
Fig. 8 Heatmap of Upstream Regulator Analysis predicted on TCP relative to PDMS. Upstream regulators predicted by IPA based on up- and
down-regulated genes (A), or based on up-regulated genes only (B). MSC were derived from two donors (MSC 1 and MSC 2). KG1a were seeded at
two densities (KG1a high and KG1a low). CB CD34+ cells were derived from two donors (CB1 and CB2) and analysed at day 4 and 6 of culture (4
replicate wells each). All other cell cultures were analysed at day 4 of culture (3 replicate wells each). Z-scores are shown where at least one cell
type had a z-score >2 or ≤2 and appear in the order of z-score rank (highest ranked to lowest ranked, from top to bottom). Activated networks
have a positive z-score (red boxes) and inhibited networks have a negative z-score (blue boxes); non-significant networks appear as grey boxes.
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Retinoid signalling is known to play a role in developmental
and biological processes involving embryonic stem cells,36,37
MSC38,39 and HSC.11,35
PDMS-based microdevices and bioreactors offer powerful
tools to interrogate biological processes in vitro,40 and thus
their use in this area is likely to continue to increase. Our
data clearly demonstrate that PDMS can perturb retinoid sig-
nalling, and influence gene expression over a range of cell
types. Retinoid depletion and conversion is further afflicted
by the chemical instability of retinoids, which are sensitive to
light and conditions used for cell culture. Microdevices are
often exposed to light during real-time microscopic analysis
and medium is fed through lengthy tubes and PDMS chan-
nels. The depletion of retinoids in microdevices, and other
molecules with similar chemical properties, can significantly
perturb biological outcomes, as compared to traditional static
cultures in TCP dishes. We recommend that PDMS-mediated
retinoid signalling perturbation be considered as a possible
culture artefact when interpreting biological data from
PDMS-based cell culture devices.
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